liposomal delivery is designed to support absorption at the cellular level, ensuring your body actually benefits from the Vitamin C you take
Manufacturing Process 9.3 g of epichlorohydrin was added at a temperature of 40-50C under stirring to 9.6 g of trimethylamine hydrochloride dissolved in 10 cc of water
It is approved for chronic weight management in adults and children 6 years and older with obesity due to specific genetic conditions, including proopiomelanocortin (POMC), proprotein convertase subtilisin/kexin type 1 (PCSK1), or leptin receptor (LEPR) deficiency, or Bardet-Biedl syndrome
Short History: Developed by Shionogi & AstraZeneca First approved: 2003 Discovery country: Japan / United Kingdom collaboration Designed as a high-potency synthetic statin with longer half-life #Rosuvastatin #Statins #Pharmacology #MedicineOfTheDay #PharmacyLife #ClinicalPharmacy #CardiovascularHealth #Cholesterol #Dyslipidemia #Pharmacist #RehanKhan #Rosuvastatin #Statins #HMGCoAReductaseInhibitors #LipidLoweringTherapy #Dyslipidemia #CholesterolManagement #CardiovascularPrevention #HeartHealth #Pharmacology #ClinicalPharmacy #PharmacyEducation #MedicineOfTheDay #365DaysChallenge #PharmacistLife #HealthcareProfessionals #DrugEducation #MedicalKnowledge #PharmacyStudents #EvidenceBasedMedicine To view or add a comment, sign in Rosuvastatin Drug Class: Statin (HMG-CoA Reductase Inhibitor) Lipid-lowering agent Indications / Uses: Hypercholesterolemia ( LDL-C) Mixed dyslipidemia Hypertriglyceridemia Prevention of cardiovascular events (MI, stroke) Familial hypercholesterolemia Mechanism of Action (MOA): Rosuvastatin inhibits HMG-CoA reductase, the rate-limiting enzyme in hepatic cholesterol synthesis Cholesterol production in liver LDL cholesterol & triglycerides HDL cholesterol LDL receptor expression increased LDL clearance Dose: Usual starting: 1020 mg once daily Maintenance: 540 mg once daily Severe hypercholesterolemia: up to 40 mg/day Renal impairment: lower starting dose recommended Adverse Effects: Myalgia / muscle pain Elevated liver enzymes Headache Nausea Risk of rhabdomyolysis (rare) Slight increase in blood glucose Drug Interactions: Cyclosporine rosuvastatin levels Gemfibrozil risk of myopathy Warfarin anticoagulant effect Antacids (Al/Mg) absorption Protease inhibitors statin toxicity risk Contraindications: Active liver disease Pregnancy Breastfeeding Hypersensitivity Clinical Pearl: Rosuvastatin is one of the most potent statins with strong LDL-lowering ability and proven cardiovascular risk reduction, often effective at lower doses compared to other statins
Si bien los agonistas GLP1 son medicamentos seguros, con baja posibilidad de hipoglicemia, sus efectos negativos sobre la motilidad del aparato digestivo generan que los sntomas gastrointestinales sean los efectos adversos ms frecuentes
